|
| 25810701 | EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclides. | Radiol Oncol | 2015 |
| 24403002 | Antibody performance in western blot applications is context-dependent. | Biotechnol J | 2014 |
| 23455178 | Evaluation of real-time immunohistochemistry and interaction map as an alternative objective assessment of HER2 expression in human breast cancer tissue. | Appl Immunohistochem Mol Morphol | 2013 |
| 23470167 | Tumour expression of bladder cancer-associated urinary proteins. | BJU Int | 2013 |
| 22065568 | Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer. | Proteomics | 2012 |
| 22307465 | A novel CD44v6 targeting antibody fragment with improved tumor-to-blood ratio. | Int J Oncol | 2012 |
| 22274646 | Insulin-secreting INS-1E cells express functional TRPV1 channels. | Islets | 2012 |
| 21034352 | Diagnostic biomarkers of prostate cancer. | Scand J Urol Nephrol | 2011 |
| 22137850 | Comparative biodistribution of imaging agents for in vivo molecular profiling of disseminated prostate cancer in mice bearing prostate cancer xenografts: focus on 111In- and 125I-labeled anti-HER2 humanized monoclonal trastuzumab and ABY-025 affibody. | Nucl Med Biol | 2011 |
| 21677534 | SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas. | Am J Surg Pathol | 2011 |
| 21109951 | EGFR, HER2 and HER3 expression in primary colorectal carcinomas and corresponding metastases: Implications for targeted radionuclide therapy. | Oncol Rep | 2011 |
| 21091088 | GAD1 is a biomarker for benign and malignant prostatic tissue. | Scand J Urol Nephrol | 2011 |
| 19821490 | Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma. | Int J Cancer | 2010 |
| 21139605 | Towards a knowledge-based Human Protein Atlas. | Nat Biotechnol | 2010 |
| 20412121 | Subcellular distribution and expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in malignant glioma: Influence on cell survival and migration. | Cancer Sci | 2010 |
| 19901271 | The impact of tissue fixatives on morphology and antibody-based protein profiling in tissues and cells. | J Histochem Cytochem | 2010 |
| 18953328 | Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas. | Mod Pathol | 2009 |
| 20029370 | A global view of protein expression in human cells, tissues, and organs. | Mol Syst Biol | 2009 |
| 19522865 | A novel strategy based on histological protein profiling in-silico for identifying potential biomarkers in urinary bladder cancer. | BJU Int | 2009 |
| 19108777 | Characterization of PrEST-based antibodies towards human Cytokeratin-17. | J Immunol Methods | 2009 |
| 19167192 | DLG3/SAP102 protein expression in malformations of cortical development: a study of human epileptic cortex by tissue microarray. | Epilepsy Res | 2009 |
| 18395978 | Expression profile of PRAF2 in the human brain and enrichment in synaptic vesicles. | Neurosci Lett | 2008 |
| 18669619 | A genecentric Human Protein Atlas for expression profiles based on antibodies. | Mol Cell Proteomics | 2008 |
| 18685494 | Evaluation of monospecific antibodies: a comparison study with commercial analogs using immunohistochemistry on tissue microarrays. | Appl Immunohistochem Mol Morphol | 2008 |
| 16920253 | Gene expression analysis for the prediction of recurrence in patients with primary Ta urothelial cell carcinoma. | Eur Urol | 2007 |
| 17992053 | Quantification of CD44v6 and EGFR expression in head and neck squamous cell carcinomas using a single-dose radioimmunoassay. | Tumour Biol | 2007 |
| 17549799 | A high-throughput strategy for protein profiling in cell microarrays using automated image analysis. | Proteomics | 2007 |
| 17575217 | Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study. | Clin Cancer Res | 2007 |
| 17671674 | EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastases. | Int J Oncol | 2007 |
| 17465243 | Simultaneous proteomic and genomic analysis of primary Ta urothelial cell carcinomas for the prediction of tumor recurrence. | Anticancer Res | 2007 |
| 16200342 | Planning for intracavitary anti-EGFR radionuclide therapy of gliomas. Literature review and data on EGFR expression. | J Neurooncol | 2006 |
| 17072308 | Direct observation of individual endogenous protein complexes in situ by proximity ligation. | Nat Methods | 2006 |
| 16721812 | Prediction of recurrence in Ta urothelial cell carcinoma by real-time quantitative PCR analysis: a microarray validation study. | Int J Cancer | 2006 |
| 16957166 | Analysis of protein expression in cell microarrays: a tool for antibody-based proteomics. | J Histochem Cytochem | 2006 |
| 16949094 | Multiplexed PrEST immunization for high-throughput affinity proteomics. | J Immunol Methods | 2006 |
| 15839918 | Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastases. | BJU Int | 2005 |
| 16237735 | Towards a human proteome atlas: high-throughput generation of mono-specific antibodies for tissue profiling. | Proteomics | 2005 |
| 16127175 | A human protein atlas for normal and cancer tissues based on antibody proteomics. | Mol Cell Proteomics | 2005 |
| 16221759 | Binding sites for metabolic disease related transcription factors inferred at base pair resolution by chromatin immunoprecipitation and genomic microarrays. | Hum Mol Genet | 2005 |
| 15809707 | Expression of EGFR, HER2, HER3, and HER4 in metastatic squamous cell carcinomas of the oral cavity and base of tongue. | Int J Oncol | 2005 |
| 15068324 | HER-2, EGFR, COX-2 expression status correlated to microvessel density and survival in resected non-small cell lung cancer. | Acta Oncol | 2004 |
| 15328478 | Endothelial markers and circulating angiogenic factors and p53 may be potential markers for recurrence in surgically resected non-small cell lung cancer patients. | Med Sci Monit | 2004 |
| 15150568 | HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review. | Br J Cancer | 2004 |
| 12746570 | Selenium protection against mercury-induced apoptosis and growth inhibition in cultured K-562 cells. | Biol Trace Elem Res | 2003 |
| 14503962 | Early effects of low dose-rate radiation on cultured tumor cells. | Cancer Biother Radiopharm | 2003 |
| 14580889 | Affibody-beta-galactosidase immunoconjugates produced as soluble fusion proteins in the Escherichia coli cytosol. | J Immunol Methods | 2003 |
| 12808124 | Zinc-based fixative improves preservation of genomic DNA and proteins in histoprocessing of human tissues. | Lab Invest | 2003 |
| 12796447 | Affinity proteomics for systematic protein profiling of chromosome 21 gene products in human tissues. | Mol Cell Proteomics | 2003 |
| 12065843 | A new antibody recognizing the vIII mutation of human epidermal growth factor receptor. | Tumour Biol | 2002 |
| 12607610 | Increased expression of adenylyl cyclase isoforms in the adrenal gland of diabetic Goto-Kakizaki rat. | Appl Immunohistochem Mol Morphol | 2002 |